These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4668457)

  • 21. [Efficacy of cardiac glycosides in circulatory insufficiency].
    Vizir AD
    Vrach Delo; 1969 Nov; 11():39-42. PubMed ID: 5384419
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of cardiac glycosides and anabolic preparations on the indices of the blood oxygen balance and carbohydrate metabolism in ischemic heart disease patients in the initial (preclinical) stage of heart failure].
    Denisiuk VI; Shkliar MB
    Ter Arkh; 1984; 56(4):64-7. PubMed ID: 6729733
    [No Abstract]   [Full Text] [Related]  

  • 23. [Various controversial problems in cardiac glycoside therapy].
    Votchal BE; Slutskiĭ ME
    Ter Arkh; 1967 Jul; 39(7):7-13. PubMed ID: 5610936
    [No Abstract]   [Full Text] [Related]  

  • 24. [Study of the therapeutic effect of a cardioactive glycoside extracted from scilla (proscillaridin A), by means of polygraphic investigations].
    Facci M
    Minerva Med; 1966 May; 57(43 Suppl):1978-82. PubMed ID: 5943255
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical use of a new cardioactive glycoside: proscillaridin A. Case studies].
    Pagliara R
    Minerva Med; 1967 Dec; 58(96):4296-301. PubMed ID: 6081717
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical study of the properties of cardiac glycoside bovoside].
    Shushliapin OI
    Vrach Delo; 1976 Sep; (9):39-42. PubMed ID: 982976
    [No Abstract]   [Full Text] [Related]  

  • 27. [Data on the hospital treatment of heart disease patients with proscillaridin A].
    Saccabusi E
    Recenti Prog Med; 1966 Jul; 41(1):XLIII-LIV. PubMed ID: 6014476
    [No Abstract]   [Full Text] [Related]  

  • 28. [Characteristics of the course of rheumatic heart disease in middle-aged and elderly patients].
    Adamova NS; Gebler NI; Gratsianov DA
    Ter Arkh; 1971 Jan; 43(1):40-4. PubMed ID: 5574535
    [No Abstract]   [Full Text] [Related]  

  • 29. [The value of analyzing the duration of the systolic phases of the left ventricle in determining the effectiveness of therapy].
    Vasil'tsev IaS; Plotnikova ND
    Ter Arkh; 1967 Jul; 39(7):104-9. PubMed ID: 5610918
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of cardiac glycosides on whole body potassium concentration in circulatory insufficiency].
    Lyskova MN; Kruglova ZG
    Kardiologiia; 1985 Dec; 25(12):70-4. PubMed ID: 3937933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Total potassium level in the body at different stages of ischemic heart disease].
    Bogoliubov VM; Kruglova ZG
    Sov Med; 1975 Apr; (4):31-5. PubMed ID: 1188456
    [No Abstract]   [Full Text] [Related]  

  • 32. [Content of total exchangeable potassium in patients with ischemic heart disease].
    Kramer AA; Sagirashvili VA; Grigoriants RA
    Kardiologiia; 1974 Oct; 14(10):78-86. PubMed ID: 4444119
    [No Abstract]   [Full Text] [Related]  

  • 33. [On the glycoside therapy of angina pectoris using Sandolanid].
    Schubert M
    Ther Ggw; 1968 Jun; 107(6):808-16. PubMed ID: 5663326
    [No Abstract]   [Full Text] [Related]  

  • 34. [Dynamics of the total left ventricular systole under the influence of cardiac glycosides with particular reference to proscillaridin A].
    Adamska-Dyniewska H
    Pol Tyg Lek; 1969 Oct; 24(40):1523-5. PubMed ID: 5365667
    [No Abstract]   [Full Text] [Related]  

  • 35. [Interrelationship between myocardial hypokalemia and the toxic effect of cardiac glycosides].
    Sokolov EI; Oreshuk FA
    Sov Med; 1967 Apr; 30(4):59-63. PubMed ID: 5608576
    [No Abstract]   [Full Text] [Related]  

  • 36. [The treatment of cardiac insufficiency of varying genesis with a new cardiac glycoside].
    Gill E
    Med Welt; 1970 Aug; 34():1472-6. PubMed ID: 5510409
    [No Abstract]   [Full Text] [Related]  

  • 37. [The antiarrhythmic and coronary-dilating properties of verapamil in patients ith ischemic heart disease].
    Votcal BE; Lozinskij LG; Goldberg VA; Venediktova MG; Gribova OA
    Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1281+. PubMed ID: 5312386
    [No Abstract]   [Full Text] [Related]  

  • 38. [Some clinical observations on the use of a cardiokinetic extract of squill: proscillaridin A. Differences from other more commonly used glycosides].
    Luise A
    Minerva Med; 1967 Dec; 58(96):4286-9. PubMed ID: 6083290
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of latent cardiac insufficiency with a new cardiac glycoside].
    Stummer E
    Ther Ggw; 1969 Aug; 108(8):1154-6 passim. PubMed ID: 5379563
    [No Abstract]   [Full Text] [Related]  

  • 40. [Concentration of potassium and sodium in the saliva, plasma and erythrocytes of patients having arteriosclerotic aortocardiosclerosis with circulatory insufficiency].
    Fedushin PS
    Vrach Delo; 1969 Mar; 3():60-3. PubMed ID: 5369658
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.